Title: SB 939 Text
Official Title: 
Number of Sections: 1
Source: versions - Originating in Committee
Media Type: text/html

================================================================================

Section 1:
SB 939 Text skip navigation SENATE PRESIDENT SENATORS COMMITTEES VIDEO/AUDIO DISTRICT MAPS SENATE CLERK SENATE RULES HOUSE SPEAKER DELEGATES COMMITTEES VIDEO/AUDIO DISTRICT MAPS HOUSE CLERK HOUSE RULES HOUSE STAFF JOINT INTERIM COMMITTEES LEGISLATIVE ADMINISTRATOR LEGISLATIVE SERVICES DIVISION PUBLIC INFORMATION LEGISLATIVE AUTOMATED SYSTEMS DIVISION LEGISLATIVE AUDITOR'S OFFICE PERFORMANCE EVALUATION & RESEARCH DIVISION POST AUDIT DIVISION BUDGET DIVISION REGULATORY AND FISCAL AFFAIRS DIVISION CLAIMS COMMISSION CRIME VICTIMS RULE-MAKING REVIEW SPECIAL INVESTIGATIONS JUDICIAL COMP. COMMISSION JOINT RULES STAFF INFO BILL STATUS BILL STATUS BILL TRACKING STATE LAW WEST VIRGINIA CODE ACTS OF THE LEGISLATURE CODE OF 1931 WV CONSTITUTION US CONSTITUTION REPORTS AGENCY REPORTS AGENCY GRANT AWARDS PERFORMANCE EVALUATIONS POST AUDITS EDUCATIONAL CITIZEN’S GUIDE INTERNSHIP PROGRAM PAGE PROGRAM PUBLICATIONS PHOTO GALLERY CAPITOL HISTORY HOW A BILL BECOMES LAW CONTACT SENATE ROSTER HOUSE ROSTER PUBLIC INFO. NEWS RELEASES HELPFUL LINKS Introduced Version - Originating in Committee Senate Bill 939 History OTHER VERSIONS  - Engrossed Version | |  Email Key: Green = existing Code. Red = new code to be enacted WEST virginia legislature2025 regular sessionOriginatingSenate Bill 939By Senators Helton, Deeds, Fuller, Takubo, Weld, and Woelfel[Originating in the Select Committee on Substance Use Disorder and Mental Health; reported March 27, 2025]A BILL to amend the Code of West Virginia, 1931, as amended, by adding a new section, designated §16B-13-4a, relating to testing for substance use disorder; and setting forth testing guidelines for office-based medication-assisted treatment facilities.Be it enacted by the Legislature of West Virginia: ARTICLE 13. MEDICATION-ASSISTED TREATMENT PROGRAM LICENSING ACT. §16B-13-4a. Progression of treatment for substance use disorder. (a) Upon being admitted as a patient to an office-based medication-assisted treatment program, the provider shall perform a comprehensive, quantitative, direct observation drug test.(b) After this time and continuing for six weeks, a direct observation, quantitative test must be performed every two weeks for six weeks.(c) Once the patient moves into the stabilization phase of treatment, the patient shall undergo a direct observation, qualitative test every 45 days for one year while in treatment.(d) Following the stabilization phase of treatment, the patient moves into the maintenance phase of treatment and during the maintenance phase of treatment shall undergo a direct observation, qualitative test every six months thereafter until discharge from the program.(e) At any point the provider wants to assess compliance, the patient must be willing to produce a direct observation qualitative or quantitative test upon the provider request. Bill Status  | Bill Tracking  | Legacy WV Code  | Bulletin Board  | District Maps  | Senate Roster  | House Roster  | Live  | Blog  | Jobs  | Links  | Home This Web site is maintained by the West Virginia Legislature's Office of Reference & Information.  | Terms of Use | Webmaster | © 2025 West Virginia Legislature ** Print On Demand Name: Email: Phone:


================================================================================

Raw Text:
SB 939 Text skip navigation SENATE PRESIDENT SENATORS COMMITTEES VIDEO/AUDIO DISTRICT MAPS SENATE CLERK SENATE RULES HOUSE SPEAKER DELEGATES COMMITTEES VIDEO/AUDIO DISTRICT MAPS HOUSE CLERK HOUSE RULES HOUSE STAFF JOINT INTERIM COMMITTEES LEGISLATIVE ADMINISTRATOR LEGISLATIVE SERVICES DIVISION PUBLIC INFORMATION LEGISLATIVE AUTOMATED SYSTEMS DIVISION LEGISLATIVE AUDITOR'S OFFICE PERFORMANCE EVALUATION & RESEARCH DIVISION POST AUDIT DIVISION BUDGET DIVISION REGULATORY AND FISCAL AFFAIRS DIVISION CLAIMS COMMISSION CRIME VICTIMS RULE-MAKING REVIEW SPECIAL INVESTIGATIONS JUDICIAL COMP. COMMISSION JOINT RULES STAFF INFO BILL STATUS BILL STATUS BILL TRACKING STATE LAW WEST VIRGINIA CODE ACTS OF THE LEGISLATURE CODE OF 1931 WV CONSTITUTION US CONSTITUTION REPORTS AGENCY REPORTS AGENCY GRANT AWARDS PERFORMANCE EVALUATIONS POST AUDITS EDUCATIONAL CITIZEN’S GUIDE INTERNSHIP PROGRAM PAGE PROGRAM PUBLICATIONS PHOTO GALLERY CAPITOL HISTORY HOW A BILL BECOMES LAW CONTACT SENATE ROSTER HOUSE ROSTER PUBLIC INFO. NEWS RELEASES HELPFUL LINKS Introduced Version - Originating in Committee Senate Bill 939 History OTHER VERSIONS  - Engrossed Version | |  Email Key: Green = existing Code. Red = new code to be enacted WEST virginia legislature2025 regular sessionOriginatingSenate Bill 939By Senators Helton, Deeds, Fuller, Takubo, Weld, and Woelfel[Originating in the Select Committee on Substance Use Disorder and Mental Health; reported March 27, 2025]A BILL to amend the Code of West Virginia, 1931, as amended, by adding a new section, designated §16B-13-4a, relating to testing for substance use disorder; and setting forth testing guidelines for office-based medication-assisted treatment facilities.Be it enacted by the Legislature of West Virginia: ARTICLE 13. MEDICATION-ASSISTED TREATMENT PROGRAM LICENSING ACT. §16B-13-4a. Progression of treatment for substance use disorder. (a) Upon being admitted as a patient to an office-based medication-assisted treatment program, the provider shall perform a comprehensive, quantitative, direct observation drug test.(b) After this time and continuing for six weeks, a direct observation, quantitative test must be performed every two weeks for six weeks.(c) Once the patient moves into the stabilization phase of treatment, the patient shall undergo a direct observation, qualitative test every 45 days for one year while in treatment.(d) Following the stabilization phase of treatment, the patient moves into the maintenance phase of treatment and during the maintenance phase of treatment shall undergo a direct observation, qualitative test every six months thereafter until discharge from the program.(e) At any point the provider wants to assess compliance, the patient must be willing to produce a direct observation qualitative or quantitative test upon the provider request. Bill Status  | Bill Tracking  | Legacy WV Code  | Bulletin Board  | District Maps  | Senate Roster  | House Roster  | Live  | Blog  | Jobs  | Links  | Home This Web site is maintained by the West Virginia Legislature's Office of Reference & Information.  | Terms of Use | Webmaster | © 2025 West Virginia Legislature ** Print On Demand Name: Email: Phone: